Eros Ferrazzí

2.5k total citations · 1 hit paper
48 papers, 1.8k citations indexed

About

Eros Ferrazzí is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Eros Ferrazzí has authored 48 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 16 papers in Molecular Biology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Eros Ferrazzí's work include Cancer Treatment and Pharmacology (8 papers), Colorectal Cancer Treatments and Studies (6 papers) and Cancer therapeutics and mechanisms (5 papers). Eros Ferrazzí is often cited by papers focused on Cancer Treatment and Pharmacology (8 papers), Colorectal Cancer Treatments and Studies (6 papers) and Cancer therapeutics and mechanisms (5 papers). Eros Ferrazzí collaborates with scholars based in Italy, Belgium and United States. Eros Ferrazzí's co-authors include Milena Gusella, Angelo Veronese, Massimo Negrini, Silvia Sabbioni, Luigi Bolondi, Laura Gramantieri, George A. Calin, Manuela Ferracin, Carlo M. Croce and Chang‐Gong Liu and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Eros Ferrazzí

46 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cyclin G1 Is a Target of miR-122a, a MicroRNA Frequently Down-regulated in Human Hepatocellular Carcinoma

2007 670 citations Laura Gramantieri, Manuela Ferracin et al. Cancer Research profile →

Peers

Eros Ferrazzí

ONCOL

PHYSI

SURGE

Lin Xia China

Liangping Xia China

Bonnie L. Kemp United States

Harun M. Said Germany

C. Sturgeon United Kingdom

Ran Zhong China

Xiaoming Xing China

R Klapdor Germany

Michael Medinger Switzerland

Zhiping Yan China

Lin Xia China

Eros Ferrazzí

1.5k ×1.7

1.1k ×1.6

615 ×1.4

ONCOL

232 ×0.9

PHYSI

320 ×1.9

SURGE

Citations per year, relative to Eros Ferrazzí Eros Ferrazzí (= 1×) peers Lin Xia

Countries citing papers authored by Eros Ferrazzí

Since Specialization

Citations

This map shows the geographic impact of Eros Ferrazzí's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eros Ferrazzí with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eros Ferrazzí more than expected).

Fields of papers citing papers by Eros Ferrazzí

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eros Ferrazzí. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eros Ferrazzí. The network helps show where Eros Ferrazzí may publish in the future.

Co-authorship network of co-authors of Eros Ferrazzí

This figure shows the co-authorship network connecting the top 25 collaborators of Eros Ferrazzí. A scholar is included among the top collaborators of Eros Ferrazzí based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eros Ferrazzí. Eros Ferrazzí is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stampalija, Tamara, C. Lees, T. Ghi, et al.. (2025). ISUOG Consensus Statement on maternal hemodynamic assessment in hypertensive disorders of pregnancy and fetal growth restriction. Ultrasound in Obstetrics and Gynecology. 66(5). 681–696. 1 indexed citations

Gusella, Milena, A.C. Frigo, Raúl A. Marinelli, et al.. (2009). Predictors of survival and toxicity in patients on adjuvant therapy with 5-fluorouracil for colorectal cancer. British Journal of Cancer. 100(10). 1549–1557. 77 indexed citations

Bononi, Antonio, Francesco Lanza, Luisa Ferrari, et al.. (2009). Predictive value of hematological and phenotypical parameters on postchemotherapy leukocyte recovery. Cytometry Part B Clinical Cytometry. 76B(5). 328–333. 8 indexed citations

Gramantieri, Laura, Manuela Ferracin, Francesca Fornari, et al.. (2007). Cyclin G1 Is a Target of miR-122a, a MicroRNA Frequently Down-regulated in Human Hepatocellular Carcinoma. Cancer Research. 67(13). 6092–6099. 670 indexed citations breakdown →

Gusella, Milena, G Crepaldi, C. Barile, et al.. (2006). Pharmacokinetic and demographic markers of 5-fluorouracil toxicity in 181 patients on adjuvant therapy for colorectal cancer. Annals of Oncology. 17(11). 1656–1660. 43 indexed citations

Gusella, Milena, et al.. (2006). A novel G/C single-nucleotide polymorphism in the double 28-bp repeat thymidylate synthase allele. The Pharmacogenomics Journal. 6(6). 421–424. 21 indexed citations

Gusella, Milena, et al.. (2005). Effect of Hemodialysis on the Metabolic Clearance of 5-Fluorouracil in a Patient With End-Stage Renal Failure. Therapeutic Drug Monitoring. 27(6). 816–818. 18 indexed citations

Miotto, Elena, Silvia Sabbioni, Angelo Veronese, et al.. (2004). Frequent Aberrant Methylation of the CDH4 Gene Promoter in Human Colorectal and Gastric Cancer. Cancer Research. 64(22). 8156–8159. 81 indexed citations

Dabusti, Melissa, Francesco Lanza, Diana Campioni, et al.. (2003). CXCR-4 Expression on Bone Marrow CD34 ⁺ Cells Prior to Mobilization Can Predict Mobilization Adequacy in Patients with Hematologic Malignancies. Journal of Hematotherapy & Stem Cell Research. 12(4). 425–434. 14 indexed citations

10.

Sabbioni, Silvia, Elena Miotto, Angelo Veronese, et al.. (2003). Multigene Methylation Analysis of Gastrointestinal Tumors. Molecular Diagnosis. 7(3). 201–207. 34 indexed citations

11.

Toso, Silvia, Antonio Piccoli, Milena Gusella, et al.. (2003). Bioimpedance vector pattern in cancer patients without disease versus locally advanced or disseminated disease. Nutrition. 19(6). 510–514. 58 indexed citations

12.

Chiarion‐Sileni, Vanna, Antonio Bononi, C. Veller Fornasa, et al.. (2002). Phase II trial of interferon‐α‐2a plus psolaren with ultraviolet light A in patients with cutaneous T‐cell lymphoma. Cancer. 95(3). 569–575. 60 indexed citations

13.

Gusella, Milena, et al.. (2002). Relationships between body composition parameters and fluorouracil pharmacokinetics. British Journal of Clinical Pharmacology. 54(2). 131–139. 75 indexed citations

14.

Gusella, Milena, et al.. (2002). New Limited Sampling Strategy for Determining 5-Fluorouracil Area Under the Concentration-Time Curve After Rapid Intravenous Bolus. Therapeutic Drug Monitoring. 24(3). 425–431. 14 indexed citations

15.

Nicoletto, Maria Ornella, Grazia Artioli, Martin Donach, et al.. (2001). Elderly Ovarian Cancer: Treatment with Mitoxantrone–Carboplatin. Gynecologic Oncology. 80(2). 221–226. 7 indexed citations

16.

Toso, Silvia, Antonio Piccoli, Milena Gusella, et al.. (2000). Altered tissue electric properties in lung cancer patients as detected by bioelectric impedance vector analysis. Nutrition. 16(2). 120–124. 172 indexed citations

17.

Nicoletto, Maria Ornella, F. Galeotti, Eros Ferrazzí, et al.. (2000). Pharmacokinetics of intraperitoneal hyperthermic perfusion with mitoxantrone in ovarian cancer. Cancer Chemotherapy and Pharmacology. 45(6). 457–462. 28 indexed citations

18.

Nicoletto, Maria Ornella, Roberto Padrini, Eros Ferrazzí, et al.. (1993). Phase I–II intraperitoneal mitoxantrone in advanced pretreated ovarian cancer. European Journal of Cancer. 29(9). 1242–1248. 10 indexed citations

19.

Ferrazzí, Eros, et al.. (1988). Antiviral activity of gyrase inhibitors norfloxacin,coumermycin A1 and nalidixic acid. Biochemical Pharmacology. 37(9). 1885–1886. 29 indexed citations

20.

Fornasiero, A., Otello Daniele, Adriano Paccagnella, et al.. (1980). Tossicità della Bleomicina Somministrata in Infusione Continua ad Alte Dosi. Tumori Journal. 66(5). 607–613. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact